Peak value anti-Xa
2022-2-2016
Unknown other active
Quick answer
Peak value anti-Xa for Venous Thromboembolism is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Venous Thromboembolism
- Phase
- Unknown
- Modality
- other
- Status
- active